|
|
| Line 21: |
Line 21: |
|
| |
|
| </StructureSection> | | </StructureSection> |
| ==3D structures of bile acid receptor==
| |
|
| |
|
| Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
| |
|
| |
| [[1osh]], [[3fli]], [[3l1b]] – hFXR LBD + non-steroidal agonist - human <br />
| |
| [[1osv]] – hFXR LBD + CDC derivative + nuclear receptor coactivator 2 peptide<br />
| |
| [[4wvd]] - hFXR LBD + nuclear receptor corepressor peptide<br />
| |
| [[3bej]], [[3dct]], [[3dcu]], [[3hc5]], [[3hc6]], [[3rut]], [[3ruu]], [[3rvf]] – hFXR LBD + non-steroidal agonist + nuclear receptor coactivator 1 peptide<br />
| |
| [[4qe6]] – hFXR LBD + CDC + nuclear receptor coactivator 2 peptide<br />
| |
| [[5ick]] – hFXR LBD + feroline + nuclear receptor coactivator 2 peptide<br />
| |
| [[5q0i]] – hFXR LBD + PPAR gamma coactivator peptide<br />
| |
| [[5q15]], [[5wzx]] – hFXR LBD + coactivator SRC peptide<br />
| |
| [[4qe8]] – hFXR LBD + DM175 + nuclear receptor coactivator 2 peptide<br />
| |
| [[5iaw]] - hFXR LBD + nuclear receptor coactivator 2 peptide + modulator<br />
| |
| [[5q0x]], [[5q0y]], [[5q0z]], [[5q10]], [[5q11]], [[5q12]], [[5q13]], [[5q14]], [[5q16]], [[5q18]], [[5q19]], [[5q1a]], [[5q1b]], [[5q1c]], [[5q1d]], [[5q1e]], [[5q1f]], [[5q1g]], [[5q1h]], [[5q1i]], [[5q01]], [[5q0j]], [[5q0k]], [[5q0l]], [[5q0m]], [[5q0n]], [[5q0o]], [[5q0p]], [[5q0r]], [[5q0q]], [[5q0s]], [[5q0t]], [[5q0u]], [[5q0v]], [[5q0w]], [[5q17]] - hFXR LBD + coactivator peptide SRC-1 HD3 + ligand<br />
| |
| [[3fxv]], [[3gd2]], [[3okh]], [[3oki]], [[3olf]], [[3omk]], [[3omm]], [[3oof]], [[3ook]], [[3p88]], [[3p89]] – hFXR LBD (mutant) + non-steroidal agonist + nuclear receptor coactivator 1 peptide<br />
| |
| [[1ot7]] – hFXR LBD + CDC derivative + RPGR-interacting protein peptide<br />
| |
| [[4oiv]] – hFXR LBD + antagonist <br />
| |
| == References == | | == References == |
| <references/> | | <references/> |
| [[Category:Topic Page]] | | [[Category:Topic Page]] |